Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US7670604B2 · kind B2 · utility
1Cited by
17References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2005 |
| Grant date | Mar 2, 2010 |
| Priority date | — |
| Expiry date | Nov 9, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for treating or preventing a neoplastic or a multidrug resistant neoplasm in a subject using cell surface vimentin targeted therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.